Psychiatry & Neurology Doctors in Chelmsford, MA Accepting Medicare

8 Psychiatry & Neurology doctors found. Showing 1 - 8

Eugene Heejin Kim, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 228 Billerica Rd, Chelmsford, MA 01824 Phone: 978-250-6240

Jonathan Harland, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 228 Billerica Rd, Chelmsford, MA 01824 Phone: 978-250-6240    Fax: 978-244-6684

Ricardo Dancel, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 3 Courthouse Ln, Suite 3 Seven Hills Behavioral Health, Chelmsford, MA 01824 Phone: 978-256-1444    Fax: 978-441-1773

Chand K Bhan, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1 Courthouse Lane, Unit 3, Chelmsford, MA 01824 Phone: 978-934-9828    Fax: 978-453-1118

Bruce J. Holstein, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 228 Billerica Rd, Chelmsford, MA 01824 Phone: 978-250-6240    Fax: 978-244-6684

James S. Harburger, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 228 Billerica Rd, Chelmsford, MA 01824 Phone: 978-250-6240    Fax: 978-244-6684

Rizwana Sabeeh, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 228 Billerica Rd, Chelmsford, MA 01824 Phone: 978-250-6240

Dr. William J. Meehan, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 228 Billerica Rd, Chelmsford, MA 01824 Phone: 978-250-6240    Fax: 978-244-6684

News Archive

Patients treated by ID physicians less likely to die in hospital

In a first-of-its-kind study to evaluate the impact of a medical specialty on patient outcomes, researchers found that hospitalized patients with severe infections such as meningitis and Clostridium difficile are significantly less likely to die if they receive care from an infectious diseases specialist. The study, which analyzed nearly 130,000 Medicare patient cases, is now available online and will be published in the December 15 issue of Clinical Infectious Diseases.

GlobalData reader's poll: Brexit will be strongly negative for medtech industry

The UK leaving the European Union today will be a strongly negative development for the medtech industry, according to a poll of GlobalData's Verdict Medical Devices readers.

Drug Tarceva improves survival chance for patients with advanced lung cancer

Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).

Hazelden, Columbia University to open collegiate addiction recovery residence in N.Y. City

Hazelden, one of the world's largest and most respected private, nonprofit alcohol and drug addiction treatment centers, announced today that it will open a first-of-its-kind collegiate recovery residence called Tribeca Twelve in New York City's Tribeca neighborhood.

CytoSorbents starts trading on The Nasdaq Capital Market

CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced that it will commence trading today on The Nasdaq Capital Market under its current ticker symbol "CTSO".

Read more Medical News

› Verified 8 days ago